Part,  Chapter, Paragraph

 1   II,     5.  1.  1|           diseases and disorders~ ~· Mood/anxiety disorders and suicide~
 2   II,     5.  5.Int|        predictor of being prescribed mood altering psychotropic drugs.
 3   II,     5.  5.Int|             with a family history of mood disorders such as depression
 4   II,     5.  5.  1|                   5.5.1. Depression, mood/anxiety disorders and suicides~ ~
 5   II,     5.  5.  1|              5.5.1.1. Introduction~ ~Mood disorders. Mood disorders,
 6   II,     5.  5.  1|       Introduction~ ~Mood disorders. Mood disorders, especially unipolar
 7   II,     5.  5.  1|          2008).~ ~Most the costs for mood disorders are indirect and
 8   II,     5.  5.  1|              one third of those with mood disorders have had a contact
 9   II,     5.  5.  1|           other anxiety disorders or mood disorders (Kessler, 2007).
10   II,     5.  5.  1|        disease, its association with mood and anxiety disorders is
11   II,     5.  5.  1|           disorders, especially with mood disorders but also with
12   II,     5.  5.  1|           health. Those relevant for mood and anxiety disorders and
13   II,     5.  5.  1|        introductory Section 5.5.1.~ ~Mood and anxiety disorders. There
14   II,     5.  5.  1|      specific data in HfA addressing mood or anxiety disorders only.
15   II,     5.  5.  1|             specific data concerning mood and anxiety disorders cannot
16   II,     5.  5.  1|        ESEMeD output include data on mood and anxiety disorders, substance
17   II,     5.  5.  1|           Other population surveys~ ~Mood and anxiety disorders.~ESEMeD
18   II,     5.  5.  1|             detail in Chapter 5.5.1. Mood Disorders.~ ~ ~
19   II,     5.  5.  1|      treatment and work days lost in mood and anxiety disorders~ ~
20   II,     5.  5.  1|           Lifetime prevalence of any mood disorder was found to be
21   II,     5.  5.  1|             prevalence rates (%) for mood and anxiety disorders as
22   II,     5.  5.  1|           and 12 month prevalence of mood and anxiety disorders in
23   II,     5.  5.  1|              third of those with any mood disorder and one fourth
24   II,     5.  5.  1|                 among those with any mood or anxiety disorder or no
25   II,     5.  5.  1|          ESEMeD Study.~ ~Anxiety and mood disorders were associated
26   II,     5.  5.  1|         three or four suffering from mood and/or anxiety disorders
27   II,     5.  5.  1|           suicidal behaviour in some mood and anxiety disorders in
28   II,     5.  5.  1|             themes, all relevant for mood and anxiety disorders and
29   II,     5.  5.  1|         Programmes concerning mental/mood disorders and suicide~ ~
30   II,     5.  5.  1|         priority areas of action for mood and anxiety disorders and
31   II,     5.  5.  1|             health and prevention of mood and anxiety disorders and
32   II,     5.  5.  1|             with relevance to mental/mood disorders and suicide~ ~
33   II,     5.  5.  1|        undertreatment of anxiety and mood disorders: results from
34   II,     5.  5.  2|       problem solving and judgement. Mood is often affected and there
35   II,     5.  8.  7| Psychological distress and depressed mood in employees with asthma,
36   II,     9.  2.  3|              disability on children. Mood disorders such as depression
37   II,     9.  3.  1|              likely to be prescribed mood altering psychotropic drugs.
38   II,     9.  5.  3|        predictor of being prescribed mood altering psychotropic drugs.
39  III,    10.  1.  1|         cultures (Rehm et al, 1996); mood management and dependency
40  III,    10.  5.  3|     disorders, the indirect costs of mood disorders (depression and
41  Key,   Ap5.  0.  0|        monochloropropandiol~monoxide~mood~morbidity~morbillivirus~